Nail, hair and skin hyperpigmentation associated with indinavir therapy [4]

AIDS

Volumn 18, Issue 11, 2004, Pages 1612-

  Terheggen, Frederick ^a   Frissen, Los ^a   Weigel, Hugo ^a   Schouten, Ineke ^a   Brinkman, Kees ^a  

^a Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; DIDANOSINE; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; RITONAVIR; ZIDOVUDINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; HAIR COLOR; HAIR DISEASE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERPIGMENTATION; KIDNEY COLIC; LETTER; MALE; NAIL PIGMENTATION; NEPHROLITHIASIS; PRIORITY JOURNAL; SKIN PIGMENTATION; VIRUS RESISTANCE;

HAIR DISEASES; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-2; HUMANS; HYPERPIGMENTATION; INDINAVIR; MALE; NAIL DISEASES;

EID: 3843125285     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000131370.90575.48     Document Type: Letter

References (10)

1. Deeks S, Smith M, Holodniy M, Kahn JO. HIV-1 protease inhibitors. A review for clinicians. JAMA 1997, 277:145-153.
2. Rahav G, Maayan S. Nail pigmentation associated with zidovudine: a review and report of a case. Scand J Infect Dis 1992, 24:557-561.
3. Granel F, Truchetet F, Grandidier M. Diffuse pigmentation (nail, mouth and skin) associated with HIV infection. Ann Dermatol Venereol 1997, 124:460-462.
4. Ward HA, Russo GG, Shrum J. Cutaneous manifestations of antiviral therapy. J Am Acad Dermatol 2002, 46:284-293.
5. Bouscarat F, Bouchard C, Bouhour D. Paronychia and pyogenic granuloma of the great toes in patients treated with indinavir. N Engl J Med 1998, 338:1776-1777.
6. d'Arminio Monforte A, Testa L, Gianotti M, Franzetti F, Sollima S, Bini T, Moroni M. Indinavir related alopecia. AIDS 1998, 12:328.
7. Calista D, Boschini A. Cutaneous side effects induced by indinavir. Eur J Dermatol 2000, 10:292-296.
8. Carr A, Samaras K, Chisolm DJ, Cooper DA. Pathogenesis of HIV-1 protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia and insulin resistance. Lancet 1998, 352:1881-1883.
9. Orlow SJ, Chakraborty AK, Pawelek JM. Retinoic acid is a potent inhibitor of inducible pigmentation in murine and hamster melanoma cell lines. J Invest Dermatol 1990, 94:461-464.
10. Rafal ES, Griffiths CE, Ditre CM, et al. Topical tretinoin (retinoic acid) treatment for liver spots associated with photodamage. N Engl J Med 1992, 326:368-374.